Apimeds Pharmaceuticals US, Inc. logo

APUSApimeds Pharmaceuticals US, Inc.

NYSE MKT · Healthcare · Drug Manufacturers - Specialty & Generic

$2.78

-$0.76 (-21.47%)

Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on NYSE MKT. It is led by Vinod Menon, based in B4-204A5, Business Centre 04, Ras al-Khaimah, United Arab Emirates, with about 2 employees. Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Net income was -$1.8M. APUS currently screens at market cap $2.4M.

Use this APUS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the APUS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the APUS SEC filings page. Lician reads the product cache first so this HTML stays unique to Apimeds Pharmaceuticals US, Inc. even when a live quote feed is slow.

About Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

APUS Key Statistics

Market Cap

$2.36M

Volume

48,871

Previous Close

$4.75

Day Range

$4.72$5.34

00

EPS

-$0.18

Revenue

$0.00

Net Income

-$1.39M

Gross Profit

$0.00

Free Cash Flow

$0.00

Employees

2

APUS Financials

Annual income statement in USD. Latest reported periods first.

APUS annual income statement across FY2024, FY2023
LineFY2024FY2023
Revenue$0.00$0.00
Cost of Revenue$0.00$0.00
Gross Profit$0.00$0.00
Operating Income$0.00$0.00
Net Income-$1.39M-$777.69K
EPS (Diluted)-$0.18-$0.17

Total Assets

$13.06K

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$3.46K

Operating Cash Flow

-$733.53K

Free Cash Flow

$0.00

Apimeds Pharmaceuticals US, Inc. Company Information

Founder, CEO & Director
Vinod Menon
Headquarters
B4-204A5, Business Centre 04, Ras al-Khaimah, United Arab Emirates
Phone
848 201 5010
IPO / Founded
2025-05-09
Industry
Drug Manufacturers - Specialty & Generic
Data Updated:

Upcoming Events for APUS